Yoshiyama Annie

Track

Insider profile

Performance

Overall performance
3.3
Performance over holding periods
3.3
30 days 90 days 120 days
Average return 7% 8.2% 15.1%
Success rate 83% 68% 82%
Transactions
3 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Yoshiyama Annie's trades of Allogene Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
460.93
Quantity 67,786
Value US$349,452
Transaction date
Proposed sale
Price
1.72
Quantity 4,167
Value US$7,178
Transaction date
Proposed sale
Price
1.41
Quantity 9,601
Value US$13,537
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-04-23 2026-04-21
S Sale
16,561 +11.7%
119.29
US$974,685 		16,561 +11.7% 119.29 US$974,685
2026-04-21 2026-04-21
PrS Proposed sale
67,786
460.93
US$349,452 		67,786 460.93 US$349,452
2026-02-04 2026-02-02
S Sale
89,541 -38.8%
193.52
US$2,215,372 		89,541 -38.8% 193.52 US$2,215,372
2026-02-02 2026-02-02
PrS Proposed sale
4,167
1.72
US$7,178 		4,167 1.72 US$7,178
2025-04-23 2025-04-21
S Sale
9,601 -6.8%
1.41
US$13,537 		9,601 -6.8% 1.41 US$13,537
2025-04-21 2025-04-21
PrS Proposed sale
9,601
1.41
US$13,537 		9,601 1.41 US$13,537